111 results
8-K
EX-10.1
FATE
Fate Therapeutics Inc
20 Mar 24
Fate Therapeutics Announces Pricing of $100 Million Underwritten Offering and Concurrent Private Placement
5:32pm
10-K
2023 FY
EX-10.41
FATE
Fate Therapeutics Inc
Annual report
26 Feb 24
4:10pm
10-K
2023 FY
EX-10.42
FATE
Fate Therapeutics Inc
Annual report
26 Feb 24
4:10pm
10-Q
2023 Q2
EX-10.1
FATE
Fate Therapeutics Inc
Quarterly report
8 Aug 23
4:09pm
8-K
EX-10.1
FATE
Fate Therapeutics Inc
7 Nov 22
Fate Therapeutics Announces Exercise by ONO Pharmaceutical of Option to HER2-targeted CAR T-Cell Product Candidate for Solid Tumors
1:21pm
8-K
EX-10.1
euxz06n8dbq6su j2b2
19 Aug 20
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
4:01pm